CARISMA Therapeutics Inc (CARM)
1.00
+0.02
(+1.52%)
USD |
NASDAQ |
Sep 27, 16:00
1.00
0.00 (0.00%)
After-Hours: 18:37
CARISMA Therapeutics Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2024 | 0.00 |
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
Date | Value |
---|---|
March 31, 2023 | 0.00 |
December 31, 2022 | -0.2147 |
September 30, 2022 | |
June 30, 2022 | -2.228 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-2.228
Minimum
Jun 2022
--
Maximum
Mar 2023
-0.3053
Average
--
Median
Mar 2023
Debt to Equity Ratio Benchmarks
Moderna Inc | 0.00 |
NovaBay Pharmaceuticals Inc | -1.128 |
Palatin Technologies Inc | -- |
iBio Inc | 0.0461 |
Theriva Biologics Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 59.34M |
Total Liabilities (Quarterly) | 58.98M |
Shareholders Equity (Quarterly) | 0.36M |
Current Ratio | 3.248 |